Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID‐19 pandemic: The Princess Margaret experience and proposal-Reference-Cited by-同舟云学术

Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID‐19 pandemic: The Princess Margaret experience and proposal

Published:2020-06 Issue:15 Volume:126 Page:3426-3437
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Huang Shao Hui¹²^ORCID,O’Sullivan Brian¹²,Su Jie³,Ringash Jolie¹,Bratman Scott V.¹,Kim John¹,Hosni Ali¹^ORCID,Bayley Andrew¹,Cho John¹,Giuliani Meredith¹,Hope Andrew¹,Spreafico Anna⁴,Hansen Aaron R.⁴^ORCID,Siu Lillian L.⁴,Gilbert Ralph²⁵,Irish Jonathan C.²⁵,Goldstein David²⁵,Almeida John²⁵^ORCID,Tong Li¹,Xu Wei⁴,Waldron John¹²

Affiliation:

1. Department of Radiation Oncology Princess Margaret Cancer Centre/University of Toronto Toronto Ontario Canada

2. Department of Otolaryngology–Head and Neck Surgery Princess Margaret Cancer Centre/University of Toronto Toronto Ontario Canada

3. Department of Biostatistics Princess Margaret Cancer Centre/University of Toronto Toronto Ontario Canada

4. Division of Medical Oncology Princess Margaret Cancer Centre/University of Toronto Toronto Ontario Canada

5. Department of Surgical Oncology Princess Margaret Cancer Centre/University of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32968

Reference37 articles.

1. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

2. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

3. Clinical characteristics of COVID‐19–infected cancer patients: a retrospective case study in three hospitals within Wuhan, China;Zhang L;Ann Oncol

4. Tumor progression in waiting time for radiotherapy in head and neck cancer

5. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I/II study evaluating the feasibility and safety of delivering adjuvant hypofractionated radiotherapy in resected oral cavity cancers (HYPO-ART study);Oral Oncology Reports;2024-06

2. Latin American Consensus on the Treatment of Head and Neck Cancer;JCO Global Oncology;2024-04

3. 190 hypofractionated radiotherapy in elderly/frail head and neck cancer patients: our experience from COVID-19 pandemic.;Radiotherapy and Oncology;2024-03

4. Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment;Radiotherapy and Oncology;2023-11

5. Intensity Modulated Radiation Therapy Alone Versus Intensity Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial;International Journal of Radiation Oncology*Biology*Physics;2023-09